PD-Rx Recalls Clonidine Hydrochloride Tablets Due to cGMP Deviations
PD-Rx Pharmaceuticals is recalling 9 bottles of Clonidine Hydrochloride Tablets, 0.1 mg, distributed in Alabama due to cGMP deviations.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, which typically involves a situation where use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences. The source does not report any illnesses or injuries, and the hazard is related to manufacturing deviations rather than a specific high-risk pathogen or structural defect.
Plain-English summary
PD-Rx Pharmaceuticals, Inc. is voluntarily recalling 9 bottles of Clonidine Hydrochloride Tablets, USP, 0.1 mg, 100-count bottles. The product is prescription-only and was packaged by PD-Rx Pharmaceuticals, Inc. in Oklahoma City, OK, and manufactured by Mutual Pharm. Co. Inc. in Philadelphia, PA. The specific lot number is B14D26 with an expiration date of 02/16.
The recall was initiated because of Current Good Manufacturing Practice (cGMP) deviations. The affected product was distributed in Alabama. The recall was initiated on July 10, 2015, and was classified as Class II by the FDA.
Consumers who have this specific lot of Clonidine Hydrochloride Tablets should stop using the product and contact their healthcare provider or pharmacist for guidance. The recall was terminated on March 8, 2017.
The recalled product
- Product
- Clonidine Hydrochloride Tablets, USP, 0.1 mg, 100-count bottles, Rx only, Packaged by PD-RX Pharmaceuticals, Inc., Oklahoma City, OK 73127, MFG: Mutual Pharm. Co. Inc., Philadelphia, PA 19124, NDC 43063-509-01
- Manufacturer
- PD-Rx Pharmaceuticals, Inc.
- Category
- Drug — Prescription Medication
- Hazard
- Affected units
- 9
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot# B14D26
- Exp 02/16
Distribution
Distributed in 1 state:
Related recalls
Same manufacturer · PD-Rx Pharmaceuticals, Inc.
See all →- HighDULoxetine tablets recalled for excess nitrosamine impurity
FDA (Drugs) · 2025-01-01
- ModerateSimvastatin USP Tablets Recalled Due to Manufacturing Quality Deviations
FDA (Drugs) · 2023-05-10
- ModerateDrug Recall: Montelukast Sodium Tablets Due to Manufacturing Deviations
FDA (Drugs) · 2023-05-10
- ModerateDrug Recall: Glimepiride 4 mg for Manufacturing Practice Deviations
FDA (Drugs) · 2023-05-10
- ModerateSimvastatin 40 mg recalled nationwide for manufacturing quality deviations
FDA (Drugs) · 2023-05-10
Same hazard · cGMP deviations
See all →- ModerateNutralox Mint Antacid Chewable Tablets Recalled for cGMP Deviations
FDA (Drugs) · 2022-02-09
- SevereLOTRIMIN AF Powder Spray Recalled for Benzene Contamination Risk
FDA (Drugs) · 2021-11-24
- SevereMEDICALLY MINDED Hand Sanitizer Gel Recalled for Methanol Contamination
FDA (Drugs) · 2021-09-08
- ModerateYacana Alcohol Antiseptic Recalled for cGMP Deviations in Texas
FDA (Drugs) · 2020-09-30
- ModerateBersih Hand Sanitizer Gel Recalled for cGMP Deviations
FDA (Drugs) · 2020-09-09